Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LYELL IMMUNOPHARMA, INC.

(LYEL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Add to Afternoon Gains

06/17/2021 | 04:02pm EDT


ę MT Newswires 2021
All news about LYELL IMMUNOPHARMA, INC.
07/12LYELL IMMUNOPHARMA : JPMorgan Starts Lyell Immunopharma at Overweight With $22 P..
MT
07/12LYELL IMMUNOPHARMA : Morgan Stanley Starts Lyell Immunopharma at Overweight With..
MT
07/12LYELL IMMUNOPHARMA : BofA Securities Starts Lyell Immunopharma at Buy With $25 P..
MT
07/12LYELL IMMUNOPHARMA : Goldman Sachs Starts Lyell Immunopharma at Buy With $30 Pri..
MT
06/17SECTOR UPDATE : Health Care Stocks Add to Afternoon Gains
MT
06/17UPDATE : Lyell Immunopharma Drops in Nasdaq Debut After IPO
MT
06/17LYELL IMMUNOPHARMA : Prices IPO at $17 Per Share
MT
06/16Lyell Immunopharma Announces Pricing of Initial Public Offering
GL
More news
Financials (USD)
Sales 2021 9,23 M - -
Net income 2021 -285 M - -
Net cash 2021 193 M - -
P/E ratio 2021 -9,34x
Yield 2021 -
Capitalization 3 690 M 3 690 M -
EV / Sales 2021 379x
EV / Sales 2022 132x
Nbr of Employees 189
Free-Float 84,0%
Chart LYELL IMMUNOPHARMA, INC.
Duration : Period :
Lyell Immunopharma, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 15,55 $
Average target price 25,50 $
Spread / Average Target 64,0%
EPS Revisions
Managers and Directors
Elizabeth Homans Chief Executive Officer & Director
Charles Newton Chief Financial Officer
Richard D. Klausner Executive Chairman
Stephen Hill Chief Technical Operations Officer
Nicholas Restifo Executive Vice President-Research
Sector and Competitors
1st jan.Capi. (M$)
LYELL IMMUNOPHARMA, INC.0.00%3 690
GILEAD SCIENCES, INC.17.32%85 723
BIONTECH SE331.56%82 168
WUXI APPTEC CO., LTD.41.52%69 241
REGENERON PHARMACEUTICALS19.46%59 765
VERTEX PHARMACEUTICALS-15.36%51 450